Contact
DMCA
Privacy
Robuta
https://www.biospace.com/alnylam-pharmaceuticals-initiates-phase-i-clinical-study-for-aln-ttrsc-a-subcutaneously-administered-rnai-therapeutic-targeting-transthyretin-ttr-f
Alnylam Pharmaceuticals Initiates Phase I Clinical Study for ALN-TTRsc, a Subcutaneously...
alnylam pharmaceuticals
clinical study
initiates
phase
https://www.gyretx.com/publications/preclinical-evaluation-of-a-next-generation-subcutaneously-administered-coagulation-factor-ix-variant-dalcinonacog-alfa/
Preclinical evaluation of a next-generation, subcutaneously administered, coagulation factor IX...
next generation
coagulation factor
preclinical
evaluation
subcutaneously